Skip Navigation LinksHome > July 2013 - Volume 21 - Issue 4 > Use of Ceftaroline in the Management of Vertebral Osteomyeli...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e318276959f
Case Reports

Use of Ceftaroline in the Management of Vertebral Osteomyelitis: Case Report

Zainah, Hadeel MD; Hammoud, Marwa MD; Vazquez, Jose A. MD

Collapse Box


Abstract: Ceftaroline is a novel broad-spectrum cephalosporin that has activity against gram-negative and gram-positive bacteria including methicillin-resistant Staphylococcus aureus. It was approved by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in October 2010. We report 2 cases of S aureus vertebral osteomyelitis treated effectively with ceftaroline.

© 2013 by Lippincott Williams & Wilkins.

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.